UNDP announces public procurement of medicines in five areas
The United Nations Development Program (UNDP) has announced procurements of medicines in five areas for funds remaining in the 2017 budget.
These are medicines for children suffering from mental disorders and autism (21 lots), for children and adults suffering from cystic fibrosis (five lots), medicines for the treatment of tuberculosis (33 lots), tests and consumables for TB diagnosis (14 lots), as well as medicines for children with congenital immunodeficiency (14 lots), Ukraine's Health Ministry said.
As reported, the ministry on July 27, 2017, signed contracts worth UAH 5.9 billion with UNDP, the United Nations Children's Fund (UNICEF) and Britain's Crown Agents for the purchase of medicines and medical devices for funds of the 2017 state budget.
Advertising
Advertising
MORE ABOUT
Ministry of Finance refuses to equalize tax capacity of communities in 2025 based on population size
19:43, 16.04.2024
Biden requesting $1.5 bln from Congress for 2025 fiscal year to combat Russia’s influence
19:50, 11.03.2024
Measures to increase state budget receipts in 2024 by UAH 44.2 bln include increase in war tax, excise taxes – Ministry of Finance
14:44, 04.03.2024
Ukraine's state budget deficit in Jan 2023 down to UAH 14.9 bln due to lack of funding – Ministry of Finance
16:34, 05.02.2024
Additional needs for mobilization and rearmament in 2024 estimated at approximately UAH 700 bln – head of Rada Budget Committee
17:36, 02.02.2024
LATEST
NBU requires Getin Holding to sell Idea Bank within six months
10:09, 03.05.2024
DIM company accredits houses under construction in eOselia program
19:22, 02.05.2024
Shareholders of Interpipe Nyzhniodniprovsky Pipe Rolling Plant updates composition of supervisory board, re-elected four members for new term, incl its head
19:05, 02.05.2024
Philip Morris to invest $11 mln in launch, commercialization of new version of tobacco heating device in Ukraine
18:24, 02.05.2024
Number of transfers via NovaPay up by 18%, transactions by 24% in Q1 2024